GlaxoSmithKline plc
Notification of Transactions of
Directors and Persons Discharging Managerial Responsibility
Vesting of conditional share awards made under
the GlaxoSmithKline Share Value Plan
This notification sets out the vesting of awards over Ordinary Shares made in 2013 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group.
The restricted period for the 2013 SVP awards has now ended and the awards made to Persons Discharging Managerial Responsibility (PDMR) vested on 28 February 2016. Details are given in the table below.
Name of PDMR |
Number of Ordinary Shares vested |
Number of ADS vested |
Mr N Hirons* |
|
5,740 |
Mrs V Whyte |
13,070 |
|
* Mr Hirons was not a PDMR at the time of grant and has subsequently been appointed PDMR.
The Company and PDMRs were advised of these transactions on 29 February 2016.
The closing price of an Ordinary Share and of an ADS of GlaxoSmithKline plc on 26 February 2016, the business day prior to vesting, were £14.105 and US$39.14 respectively.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
1 March 2016